{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:37:04Z","timestamp":1760099824513},"reference-count":26,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3440,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Paediatrica"],"published-print":{"date-parts":[[2006,4,1]]},"DOI":"10.1080\/08035250500544955","type":"journal-article","created":{"date-parts":[[2006,2,17]],"date-time":"2006-02-17T20:10:33Z","timestamp":1140207033000},"page":"388-390","source":"Crossref","is-referenced-by-count":1,"title":["Prophylaxis with palivizumab against respiratory syncytial virus infection in infants with congenital heart disease\u2014who should receive it?"],"prefix":"10.1111","volume":"95","author":[{"given":"Jan","family":"Sunneg\u00e5rdh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"E00001","unstructured":"Morris, JA and Blount, RE, Jr and Savage, RE. (1956) Recovery of cytopathogenic agent from chimpanzees with coryza <i>Proc Soc Exp Biol Med<\/i>, 92, pp. 544 - 9."},{"key":"E00002","unstructured":"Chanock, R and Roizman, B and Myers, R. (1957) Recovery from infants with respiratory illness of a virus related to Chimpanzee corya agent (CCA) <i>Am J Hyg<\/i>, 66, pp. 281 - 90."},{"key":"E00003","unstructured":"Shay, DK and Holman, RC and Newman, RD and Liu, LL and Stout, JW and Anderson, LJ. (1999) Bronchioloitis-associated hospitalizations among US children,1980\u20131996 <i>JAMA<\/i>, 282, pp. 1440 - 6."},{"key":"E00004","unstructured":"Meissner, HC and Welliver, RC and Chartrand, SA and Chartrand, S and Law, B and Weisman, L and (1999) Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion <i>Pediatr Infect Dis J<\/i>, 18, pp. 223 - 31."},{"key":"E00005","unstructured":"Sigurs, N and Bjarnarson, R and Sigurbergsson, F and Kjellman, B. (2000) Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7 <i>Am J Respir Crit Care Med<\/i>, 161, pp. 1501 - 7."},{"key":"E00006","unstructured":"Piedimonte, G and King, KA and Holmgren, NL and Bertrand, PJ and Rodriguez, MM and Hirsch, RL. (2000) A humanized monoclonal antibody against respiratory syncytial virus (palivizumab) inhibits RSV-induced neurogenic-mediated inflammation in rat airways <i>Pediatr Res<\/i>, 47, pp. 351 - 6."},{"key":"E00007","unstructured":"Kapikian, AZ and Mitchell, RH and Chanock, RM and Shvedoff, RA and Stewart, CE. (1969) An epidemiologic study of altered reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine <i>Am J Epidemiol<\/i>, 89, pp. 405 - 21."},{"key":"E00008","unstructured":"Kahn, JS. (2000) Respiratory syncytial virus vaccine development <i>Curr Opin Pediatr<\/i>, 12, pp. 257 - 62."},{"key":"E00009","unstructured":"Black, CP. (2003) Systematic review of the biology and medical management of respiratory syncytial virus infection <i>Respir Care<\/i>, 48, pp. 209 - 31."},{"key":"E00010","unstructured":"The Impact-RSV Study Group. (1998) Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory virus infection in high-risk infants <i>Pediatrics<\/i>, 102, pp. 531 - 7."},{"key":"E00011","doi-asserted-by":"crossref","unstructured":"Feltes, TF and Cabalka, AK and Meissner, HC and Piazza, F and Carlin, D and Top, F and (2003) Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease <i>J Pediatr<\/i>, 143, pp. 532 - 40.","DOI":"10.1067\/S0022-3476(03)00454-2"},{"key":"E00012","unstructured":"Meberg, A and Bru, A-L. (2006) Respiratory syncytial virus infections in congenital heart defects\u2014hospitalizations and costs <i>Acta Paediatr<\/i>, 95, pp. 404 - 406."},{"key":"E00013","doi-asserted-by":"crossref","unstructured":"Hoffman, JI. (1995) Incidence of congenital heart disease: I. Postnatal incidence <i>Pediatr Cardiol<\/i>, 16, pp. 103 - 13.","DOI":"10.1007\/BF00801907"},{"key":"E00014","unstructured":"Wren, C and O'Sullivan, J. (2001) Survival with congenital heart disease and need for follow up in adult life <i>Heart<\/i>, 85, pp. 1059 - 68."},{"key":"E00015","unstructured":"Sunneg\u00e5rdhJ, JanssonJ, NygrenA.Respiratory syncytial virus (RSV) infection in infants with significant congenital heart disease. <i>Cardiol Young<\/i> 2004;14Suppl 2:87\u20138(abstract)."},{"key":"E00016","unstructured":"Khongphatthanayothin, A and Wong, PC and Samara, Y and Newth, C and Wells, W and Starnes, VA and (1999) Impact of respiratory syncytial virus infection on surgery for congenital heart disease: postoperative course and outcome <i>Crit Care Med<\/i>, 27, pp. 1974 - 81."},{"key":"E00017","unstructured":"Thorburn, K and Kerr, S and Taylor, N and van Saene, H. (2004) RSV outbreak in a paediatric intensive care unit <i>J Hosp Infect<\/i>, 57, pp. 194 - 201."},{"key":"E00018","unstructured":"Bonnet, D and Schmaltz, A and Feltes, T. (2005) Infection by the respiratory syncytial virus in infants and young children at high risk <i>Cardiol Young<\/i>, 15, pp. 256 - 65."},{"key":"E00019","unstructured":"Yount, L and Mahle, W. (2004) Economic analysis of palivizumab in infants with congenital heart disease <i>Pediatrics<\/i>, 114, pp. 1606 - 11."},{"key":"E00020","unstructured":"Rackham, O and Thorburn, K and Kerr, S. (2005) The potential impact of prophylaxis against bronchiolitis due to the respiratory syncytial virus infection in children with congenital heart malformations <i>Cardiol Young<\/i>, 15, pp. 251 - 5."},{"key":"E00021","unstructured":"Onuzo, O. (2004) Re: Recommendations for the use of palivizumab as prophylaxis against respiratory syncytial virus in infants with congenital cardiac disease <i>Cardiol Young<\/i>, 14, pp. 469."},{"key":"E00022","unstructured":"SandvikA. Bergning av kostnadsvekter til den norske versionen av DRG-systemet. Rapport nr. STF 7803583. SINTEF Unimed 2003."},{"key":"E00023","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics Committee on Infections Disease and Committee on Fetus and Newborn. (2003) Revised indications for the use of palivizumab and respiratory syncytial virus intravenous immune globulin for the prevention of respiratory syncytial infections <i>Pediatrics<\/i>, 112, pp. 1442 - 6.","DOI":"10.1542\/peds.112.6.1442"},{"key":"E00024","unstructured":"Tulloh, R and Marsh, M and Blackburn, M and Casey, F and Lenney, W and Weller, P and (2003) Recommendations for the use of palivizumab as prophylaxis against respiratory syncytial virus in infants with congenital heart disease <i>Cardiol Young<\/i>, 13, pp. 420 - 3."},{"key":"E00025","unstructured":"Tulloh, R and Feltes, T. (2005) The European Forum for Clinical Management: prophylaxis against respiratory syncytial virus in infants and young children with congenital heart disease <i>Cardiol Young<\/i>, 15, pp. 274 - 8."},{"key":"E00026","unstructured":"Handl\u00e4ggning av RSV-infektion hos hj\u00e4rtsjuka barn-kompletterande information.Information fr\u00e5n L\u00e4kemedelsverket2004;4:29\u201331."}],"container-title":["Acta Paediatrica"],"original-title":[],"link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1080%2F08035250500544955","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1080\/08035250500544955\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T16:39:37Z","timestamp":1612975177000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1080\/08035250500544955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,1]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4,1]]}},"alternative-id":["X81377074X52K42N"],"URL":"https:\/\/doi.org\/10.1080\/08035250500544955","relation":{},"ISSN":["0803-5253"],"issn-type":[{"value":"0803-5253","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4,1]]}}}